Início
Explorar
nav.journalClub
Tendências
Mais
synapse
⌘+K
Idioma
Português
Português
Antiviral therapy reduces HCC and cirrhosis risk in Chinese chronic hepatitis B patients with mildly elevated ALT | Synapse
March 3, 2026
Antiviral therapy reduces HCC and cirrhosis risk in Chinese chronic hepatitis B patients with mildly elevated ALT
JW
Jian Ming Wang
Shenyang Aerospace University
ZZ
Zhiyi Zhang
LZ
Li Zhu
Zunyi Medical University
See all
Key Points
Antiviral therapy significantly reduces the risk of hepatocellular carcinoma (HCC) and cirrhosis related to chronic hepatitis B.
Patients with mildly elevated ALT levels experienced a notable decrease in HCC risk post-therapy.
Observational analysis of Chinese patients highlights the therapeutic potential of intervention against chronic hepatitis B.
Long-term antiviral treatment may enable better health outcomes in chronic hepatitis B patients, requiring further study.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Wang et al. (Sun,) studied this question.
synapsesocial.com/papers/69a761ecc6e9836116a30035
https://doi.org/https://doi.org/10.1016/j.cgh.2026.02.008